For people whose sleep apnea is severe enough to affect daily functioning, the greater weight loss from tirzepatide or potentially retatrutide could be a deciding factor in medication choice
Common side effects include nausea, diarrhea, and mild gastrointestinal discomfort, usually dose-dependent
The goal of preserving lean muscle mass becomes even more critical in this age group, since sarcopenia (age-related muscle loss) combined with rapid weight loss can significantly impact functional capacity
Its especially common for people on weight-loss medications, since they reach their goal weight and assume they can keep it off themselves
Insurance coverage for GLP-1-linked nutrition began in Q4 2025
No guarantee exists, and surgical intervention remains necessary for some individuals after substantial loss